Stock listing
VBIO Stock Price, News, Filings & Events — Valion Bio, Inc.
Selected listing: VBIO · NASDAQ · USD · US
This page tracks Valion Bio, Inc.'s VBIO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VBIO:NASDAQ. VBIO:NASDAQ is the stock-level entry point for investors researching Valion Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valion Bio, Inc. (ticker: VBIO) is a public company based in the United States, with a market capitalization of approximately $2.1 million. The company focuses on biotechnology and related sectors. Investors can find information about Valion Bio's performance and updates on its corporate activities on its dedicated public company page.
- Ticker
- VBIO:NASDAQ
- Asset type
- Stock
- Market cap
- $2.0M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Valion Bio, Inc. VBIO:NASDAQ stock context
This page tracks Valion Bio, Inc.'s VBIO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VBIO:NASDAQ. VBIO:NASDAQ is the stock-level entry point for investors researching Valion Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valion Bio, Inc. (ticker: VBIO) is a public company based in the United States, with a market capitalization of approximately $2.1 million. The company focuses on biotechnology and related sectors. Investors can find information about Valion Bio's performance and updates on its corporate activities on its dedicated public company page.
Latest news from Valion Bio, Inc.
Valion Bio Announces Reverse Stock Split
August 27, 2026
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
August 12, 2026
Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
July 22, 2026
Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Onc...
July 14, 2026
AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for ...
June 25, 2026
Valion Bio, Inc. earnings calls
Valion Bio, Inc. (VBIO) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Tivic Health Systems, Inc. (TIVC) Q4 2025 Earnings Call
March 25, 2026 · Replay with transcript and chapters
Tivic Health Systems, Inc. (TIVC) Q3 2025 Earnings Call
November 14, 2025 · Replay with transcript and chapters
Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Tivic Health Systems, Inc. (TIVC) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call
March 21, 2025 · Replay with transcript and chapters
Research Valion Bio, Inc.
Valion Bio, Inc. investor report
Review AI stock analysis and investor report context for VBIO:NASDAQ.
Valion Bio, Inc. company profile
View the public company page for Valion Bio, Inc. on 6ix.
Valion Bio, Inc. news
Read company news and market updates connected to Valion Bio, Inc..
Valion Bio, Inc. investor events
Find investor webinars, events, and replay context for Valion Bio, Inc..